Year 2020 / Volume 112 / Number 12
Original
Efficacy and safety of radiofrequency ablation in patients with unresectable malignant biliary strictures

921-924

DOI: 10.17235/reed.2020.7023/2020

Martha Claudia Galindo Orozco, Angélica Hernández Guerrero, Juan Octavio Alonso Larraga, Eduardo Ramírez Solis, José Guillermo de la Mora Levy, María del Carmen Manzano Robleda,

Abstract
Introduction: previous studies have shown that endoscopic radiofrequency ablation in unresectable biliary duct tumors prolongs survival. Methods: this was an observational study of patients with an unresectable malignant stricture. The aim was to evaluate survival, stent patency and adverse events of radiofrequency compared with a matched control group. Results: the study included 40 patients, 12 with radiofrequency. There were no differences between baseline parameters in both groups. The survival time was longer in the radiofrequency group with no statistically significant difference (217 vs 129 days, log-rank 0.31). There was no difference in stent permeability or adverse events. Conclusion: the radiofrequency group had a three-month increase in survival, which did not reach statistical significance.
Share Button
New comment
Comments
No comments for this article
References
1. Zaheer N, Nageshwar RD, Endoscopic Palliation for Biliary and Pancreatic Malignancies: Recent Advances, Clin Endosc 2019; 52(3): 226–234.
2. Larghi A, Rimbas M, Tringali A, et al. Endoscopic radiofrequency biliary ablation treatment: a comprehensive review, Dig Endosc. 2019; May:31(3):245-255.
3. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Hepatobiliary Cancers.[Internet]. 2019 [consultado 2019 Ene 12]. Disponible en: https://www.nccn.org/professionals/physician_gls/pdf/hepatobiliary.pdf
4. American Society for Gastrointestinal Endoscopy (ASGE) Standards of Practice Committee, Anderson MA, Appalaneni V, The role of endoscopy in the evaluation and treatment of patients with biliary neoplasia, Gastrointest Endosc. 2013, Feb:77:2.
5. Kim EJ, Chung DH, Kim YJ, et al. Endobiliary radiofrequency ablation for distal extrahepatic cholangiocarcinoma: A clinicopathological study, PLoS One. 2018; 13(11):e0206694.
6. Sofi AA, Khan MA, Radiofrequency ablation combined with biliary stent placement versus stent placement alone for malignant biliary strictures: a systematic review and meta-analysis, Gastrointest Endosc 2018; 87(4):944-951.
7. Sharaiha RZ, Natov N, Glockenberg KS, et al. Comparison of metal stenting with radiofrequency ablation versus stenting alone for treating malignant biliary strictures: is there an added benefit? Dig Dis Sci. 2014; Dec:59(12):3099-102.
8. Martí Romero L, Martínez Escapa V, Intraductal ablation by radiofrequency for inoperable biliopancreatic neoplasms with jaundice: experience at a regional hospital. Rev Esp Enferm Dig. 2019 Jun;111(6):485-48
9. Yang J, Wang J, Zhou H, et al. Efficacy and safety of endoscopic radiofrequency ablation for unresectable extrahepatic cholangiocarcinoma: a randomized trial. Endoscopy 2018; 50:751-60.
10. Kallis Y, Phillips N, Steel A, et al. Analysis of Endoscopic Radiofrequency Ablation of Biliary Malignant Strictures in Pancreatic Cancer Suggests Potential Survival Benefit. Dig Dis Sci 2015; 60:3449-55.
11. Steel AW, Postgate AJ, et al. Endoscopically applied radiofrequency ablation appears to be safe in the treatment of malignant biliary obstruction. Gastrointest Endosc 2011;73:149-53
12. Tal AO, Vermehren J, et al. Intraductal endoscopic radiofrequency ablation for the treatment of hilar non-resectable malignant bile duct obstruction. World J Gastrointest Endosc 2014; 6:13-9.
13. Schmidt A, Bloechinger M, Weber A, et al. Short-term effects and adverse events of endoscopically applied radiofrequency ablation appear to be comparable with photodynamic therapy in hilar cholangiocarcinoma. United European Gastroenterol J 2016; 4:570-9
14. Yoon WJ, Kim YT, Daglilar ES, et al. Evaluation of bipolar radiofrequency ablation for occluded self-expandable metal stents in the bile duct: in vivo and in vitro study. Endoscopy 2015; 47:1167-70.
15. Mansilla-Vivar R, Argüello-Viúdez L et al. Endoluminal radiofrequency ablation with SpyGlass™ in the management of cholangiocarcinoma. Rev Esp Enferm Dig. 2019 Oct;111(10):803-805.
Related articles

Digestive Diseases Image

Malignancy of intraductal papillary neoplasm of the bile duct

DOI: 10.17235/reed.2021.8193/2021

Letter to the Editor

Sternal cutaneous metastasis of hilar cholangiocarcinoma

DOI: 10.17235/reed.2017.4979/2017

Letter to the Editor

Lupus as a paraneoplastic manifestation of cholangiocarcinoma

DOI: 10.17235/reed.2016.4064/2015

Citation tools
Galindo Orozco M, Hernández Guerrero A, Alonso Larraga J, Ramírez Solis E, de la Mora Levy J, Manzano Robleda M, et all. Efficacy and safety of radiofrequency ablation in patients with unresectable malignant biliary strictures. 7023/2020


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics
This article has received 713 visits.
This article has been downloaded 291 times.

Statistics from Dimensions


Statistics from Plum Analytics

Publication history

Received: 02/03/2020

Accepted: 08/04/2020

Online First: 12/11/2020

Published: 09/12/2020

Article revision time: 6 days

Article Online First time: 255 days

Article editing time: 282 days


Share
This article hasn't been rated yet.
Reader rating:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2023 y Creative Commons. The Spanish Journal of Gastroenterology